BioBehavioral Diagnostics Secures $8.5 Million Series A Financing.

Extract


BioBehavioral Diagnostics Secures $8.5 Million Series A Financing.

Funds Will Support Commercialization of Proprietary Diagnostic Products for the Objective Assessment of ADHD and Measurement of Response to Medication

CAMBRIDGE, Mass. -- BioBehavioral Diagnostics Company (BioBDx) announced today that it has secured an $8.5 million Series A financing co-lead by Sevin Rosen Funds and Tullis-Dickerson. BioBDx has created a proprietary diagnostic system ...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company